Washington Court Awards Quincy Biosciences and Amazon $1.9 Million in Counterfeit Supplement Case

In a recent decision, a Washington federal judge has ruled in favor of biotechnology firm Quincy Biosciences and retail giant Amazon. Together, they have been awarded nearly $1.9 million in default judgments against several individuals accused of selling counterfeit versions of Prevagen, a brain health supplement, through Amazon’s platform. These judgments were rendered after the defendants failed to appear in court or engage with the proceedings. More information about the case and its implications can be found in the Law360 article.